ADMET & DMPK

ADMET & DMPK

In vitro biomimetic HPLC and in vivo characterisation of GM6, an endogenous regulator peptide drug candidate for amyotrophic lateral sclerosis

Yazarlar: Klara Valko, Mark Kindy, James Evans, Dorothy Ko

Cilt 6 , Sayı 2 , 2018 , Sayfalar 176-189

Konular:-

DOI:10.5599/admet.547

Anahtar Kelimeler:Motoneuron degeneration,Peptide drug candidate,ADME of peptide drugs,Biomimetic properties,PK profile,Free tissue concentration vs time PK

Özet: Amyotrophic lateral sclerosis (ALS) is an idiopathic, fatal neurodegenerative disease of the human motor system. Subunits of the 33-amino acid containing motorneurontrophic factor (MNTF) have been investigated and GM6 has been found as a potential peptide therapeutic for ALS. This linear peptide drug candidate has been characterized by HPLC based physicochemical and biomimetic measurements to estimate its in vivo distribution behavior and to estimate its cell penetration and brain to plasma concentration ratio. The free tissue concentration vs time profile has been estimated using the measured physicochemical and biomimetic properties of the intact GM6 molecules and its microsomal stability. The in vitro and in vivo measurements supported the estimated in vivo distribution behavior of GM6.

ATIFLAR
Atıf Yapan Eserler
Sonuçların tamamını görmek için Asos İndeks'e üye bir üniversite ağından erişim sağlamalısınız. Kurumunuzun üye olması veya kurumunuza ücretsiz deneme erişimi sağlanması için Kütüphane ve Dokümantasyon Daire Başkanlığı ile iletişim kurabilirsiniz.
Dergi editörleri editör girişini kullanarak sisteme giriş yapabilirler. Editör girişi için tıklayınız.
KAYNAK GÖSTER
BibTex
KOPYALA
@article{2018, title={In vitro biomimetic HPLC and in vivo characterisation of GM6, an endogenous regulator peptide drug candidate for amyotrophic lateral sclerosis}, volume={6}, number={176–189}, publisher={ADMET & DMPK}, author={Klara Valko, Mark Kindy, James Evans, Dorothy Ko}, year={2018} }
APA
KOPYALA
Klara Valko, Mark Kindy, James Evans, Dorothy Ko. (2018). In vitro biomimetic HPLC and in vivo characterisation of GM6, an endogenous regulator peptide drug candidate for amyotrophic lateral sclerosis (Vol. 6). Vol. 6. ADMET & DMPK.
MLA
KOPYALA
Klara Valko, Mark Kindy, James Evans, Dorothy Ko. In Vitro Biomimetic HPLC and in Vivo Characterisation of GM6, an Endogenous Regulator Peptide Drug Candidate for Amyotrophic Lateral Sclerosis. no. 176–189, ADMET & DMPK, 2018.
Atıf Görüntüle
PDF Görüntüle
Kaynak Görüntüle
Paylaş
Dergi Bilgileri